BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Glioblastoma Multiforme
Related studies linked through entity extraction aliases.
Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
- Status
- RECRUITING
- Phase
- PHASE1
IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Vacuolar ATPase and Drug Resistance of High Grade Gliomas
- Status
- RECRUITING
- Phase
- N/A
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
- Status
- RECRUITING
- Phase
- PHASE1
Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
- Status
- RECRUITING
- Phase
- NA
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Chlorpromazine and Standard of Care in Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Study of Pembrolizumab and M032 (NSC 733972)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1
Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients
- Status
- UNKNOWN
- Phase
- PHASE1
hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
- Status
- RECRUITING
- Phase
- PHASE2
Study of DSP-0390 in Patients With Recurrent High-Grade Glioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1